Sanofi to start selling own generic Plavix-report

PARIS Oct 5 (Reuters) - Sanofi-Aventis (SASY.PA) will start selling its own generic version of its blood-clot treatment Plavix this week through its Winthrop unit, La Lettre de L'Expansion reports on Monday.

The move is aimed at beating other generic drug makers, which are planning to sell their own versions this autumn, the French newsletter said.

La Lettre de L'Expansion did not specify on which markets Sanofi planned to launch the generic version of Plavix.

A Sanofi spokesman said the group's strategy was to sell its own version of generic drugs when appropriate but he had no immediate comment on the timing of a Plavix launch. (Reporting by Dominique Vidalon, Ben Hirschler; Editing by Hans Peters)